Recent Updates
Recently added Catalysts
KYMR Positive Sentiment Score: 60/100

Kymera Therapeutics to Present in Fireside Chat at the UBS Virtual Targeted Protein Degradation Day

Tuesday, July 9, 2024 1 min read
Key Takeaway: Kymera Therapeutics has announced its participation in a fireside chat at the UBS Virtual Targeted Protein Degradation Day, scheduled for July 15, 2024. The event will be accessible via a live webcast on the company's website. This engagement underscores Kymera's advancements in targeted protein degradation technology in the biopharmaceutical space.

Market Sentiment Analysis

POSITIVE FACTORS

  • Kymera Therapeutics is actively engaging with investors.
  • The company is advancing a new class of medicines.
  • Participation in a respected event highlights their innovation.

Full Press Release Details

WATERTOWN, Mass., July 09, 2024 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of small molecule medicines using targeted protein degradation (TPD), today announced that the Company will participate in a fireside chat at the UBS Virtual TPD Day on July 15, 2024, at 1:00 p.m. ET.
A live webcast of the presentation will be available under “News and Events” in the Investors section of the Company’s website at www.kymeratx.com. A replay of the webcast will be archived and available following the event.
About Kymera Therapeutics

Tags

Targeted Protein Degradation

Frequently Asked Questions

What event will Kymera Therapeutics join?

Kymera Therapeutics will participate in the UBS Virtual TPD Day.

When is the UBS Virtual TPD Day scheduled?

The event is scheduled for July 15, 2024, at 1:00 p.m. ET.

Where can I watch the Kymera Therapeutics presentation?

The presentation can be streamed under ‘News and Events’ on their website.

Will there be a replay of the presentation?

Yes, a replay of the webcast will be available after the event.

Tags: KYMR Viatris Investor Conferences Healthcare Kymera Therapeutics UBS Virtual TPD Day targeted protein degradation biopharmaceutical
Last updated: Jul 9, 2024